News
A new study has found that an antibiotic for liver disease patients could expose them to greater risk of a dangerous superbug. The international team of researchers found that an antibiotic ...
Hosted on MSN6mon
Study Links Common Antibiotics To Increase In Untreatable SuperbugA recent study published on Thursday has identified a common antibiotic that is causing the rise of an almost untreatable superbug. The study was led by the University of Melbourne, Peter Doherty ...
Minimally absorbed (<0.4%) rifaximin can effectively reduce the occurrence of travelers' diarrhea without side effects. Bismuth subsalicylate is a useful alternative, although it is less effective ...
“With rifaximin, one could expect not only improvement in hepatic encephalopathy but also a decreased infection rate, the most common trigger of acute-on-chronic liver failure [ACLF].
Rifaximin has already been successfully used in adults with SIBO and IBS. Aim: To assess the SIBO prevalence and symptoms improvement in IBS children after treatment with Rifaximin. Study design ...
Find all the commercial and brand names of generic drug called Rifaximin. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results